RHD Control in the 21st Century: From Evidence to Innovation to Implementation
Grand rounds objectives:
Upon completion of this program, attendees should be able to:
- Describe the historical context of acute rheumatic fever (ARF) and rheumatic heart disease (RHD), including their epidemiology and the factors driving persistent global burden in low- and middle-income countries
- Identify emerging innovations in RHD prevention, detection, and management — such as echocardiographic screening, novel therapeutics, and point-of-care diagnostics — and assess their potential to transform care in high-burden settings.
- Apply an implementation science framework to bridge the gap between evidence-based RHD interventions and real-world delivery, recognizing the structural, systemic, and community-level factors that influence equitable scale-up
accreditation for cardiovascular grand rounds
The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 36.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit)
To request disability accommodation, contact the Office of the Disability Services Office at least ten days in advance of the event at 206-543-6450 (voice), 206-543-6452 (TTY), 206-685-7264 (FAX), dso@uw.edu
The members of the Grand Rounds Committee have no disclosures relevant to this series
Professor of Pediatrics
Division of Cardiology, Heart Institute
Cincinnati Children’s Hospital Medical Center